Israeli Personalized Medicine Center Gets $50M Donation | GenomeWeb

NEW YORK (GenomeWeb News) – The Weizmann Institute of Science has received a $50 million donation to fund operations at the new Israel National Center for Personalized Medicine (INCPM), which is located at the Weizmann campus in Rehovot, Israel.

The INCPM is focused on conducting research involving genomics, protein profiling, bioinformatics, and drug discovery to advance new personalized approaches to diagnosing, treating, and preventing diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.